Dr Alison McCaig

  • Affiliate (School of Cancer Sciences)

email: Alison.McCaig@glasgow.ac.uk

R319 Level 3, Paul O'Gorman Research Centre, Gartnavel General Hospital, Glasgow G11 0YN

Import to contacts

Publications

List by: Type | Date

Jump to: 2019 | 2015 | 2013 | 2012 | 2011 | 2010
Number of items: 7.

2019

Cosimo, E. et al. (2019) AKT/mTORC2 inhibition activates FOXO1 function in CLL cells reducing B cell receptor-mediated survival. Clinical Cancer Research, 25(5), pp. 1574-1587. (doi: 10.1158/1078-0432.CCR-18-2036) (PMID:30559170) (PMCID:PMC6398589)

2015

Nakagawa, R. et al. (2015) Generation of a poor prognostic chronic lymphocytic leukemia-like disease model: PKC subversion induces up-regulation of PKC II expression in B lymphocytes. Haematologica, 100(4), pp. 499-510. (doi: 10.3324/haematol.2014.112276) (PMID:25616575) (PMCID:PMC4380723)

Middleton, O., Cosimo, E., Dobbin, E., McCaig, A.M., Clarke, C., Brant, A.M., Leach, M.T., Michie, A.M. ORCID logoORCID: https://orcid.org/0000-0002-5404-475X and Wheadon, H. ORCID logoORCID: https://orcid.org/0000-0001-9902-3170 (2015) Complement deficiencies limit CD20 monoclonal antibody treatment efficacy in CLL. Leukemia, 29(1), pp. 107-114. (doi: 10.1038/leu.2014.146) (PMID:24787488)

2013

Cosimo, E. et al. (2013) Inhibition of NF-κB-mediated signaling by the cyclin-dependent kinase inhibitor CR8 overcomes pro-survival stimuli to induce apoptosis in chronic lymphocytic leukemia cells. Clinical Cancer Research, 19(9), pp. 2393-2405. (doi: 10.1158/1078-0432.CCR-12-2170)

2012

McCaig, Alison M., Cosimo, Emilio, Leach, Michael T. and Michie, Alison M. ORCID logoORCID: https://orcid.org/0000-0002-5404-475X (2012) Dasatinib inhibits CXCR4 signaling in chronic lymphocytic leukaemia cells and impairs migration towards CXCL12. PLoS ONE, 7(11), e48929. (doi: 10.1371/journal.pone.0048929) (PMID:23133664) (PMCID:PMC3487834)

2011

McCaig, Alison M., Cosimo, Emilio, Leach, Michael T. and Michie, Alison M. ORCID logoORCID: https://orcid.org/0000-0002-5404-475X (2011) Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro-survival microenvironmental signals. British Journal of Haematology, 153(2), pp. 199-211. (doi: 10.1111/j.1365-2141.2010.08507.x)

2010

Michie, Alison M. ORCID logoORCID: https://orcid.org/0000-0002-5404-475X, McCaig, Alison M., Nakagawa, Rinako and Vukovic, Milica (2010) Death-associated protein kinase (DAPK) and signal transduction: regulation in cancer. FEBS Journal, 277(1), pp. 74-80. (doi: 10.1111/j.1742-4658.2009.07414.x)

This list was generated on Fri Jul 4 16:19:14 2025 BST.
Jump to: Articles
Number of items: 7.

Articles

Cosimo, E. et al. (2019) AKT/mTORC2 inhibition activates FOXO1 function in CLL cells reducing B cell receptor-mediated survival. Clinical Cancer Research, 25(5), pp. 1574-1587. (doi: 10.1158/1078-0432.CCR-18-2036) (PMID:30559170) (PMCID:PMC6398589)

Nakagawa, R. et al. (2015) Generation of a poor prognostic chronic lymphocytic leukemia-like disease model: PKC subversion induces up-regulation of PKC II expression in B lymphocytes. Haematologica, 100(4), pp. 499-510. (doi: 10.3324/haematol.2014.112276) (PMID:25616575) (PMCID:PMC4380723)

Middleton, O., Cosimo, E., Dobbin, E., McCaig, A.M., Clarke, C., Brant, A.M., Leach, M.T., Michie, A.M. ORCID logoORCID: https://orcid.org/0000-0002-5404-475X and Wheadon, H. ORCID logoORCID: https://orcid.org/0000-0001-9902-3170 (2015) Complement deficiencies limit CD20 monoclonal antibody treatment efficacy in CLL. Leukemia, 29(1), pp. 107-114. (doi: 10.1038/leu.2014.146) (PMID:24787488)

Cosimo, E. et al. (2013) Inhibition of NF-κB-mediated signaling by the cyclin-dependent kinase inhibitor CR8 overcomes pro-survival stimuli to induce apoptosis in chronic lymphocytic leukemia cells. Clinical Cancer Research, 19(9), pp. 2393-2405. (doi: 10.1158/1078-0432.CCR-12-2170)

McCaig, Alison M., Cosimo, Emilio, Leach, Michael T. and Michie, Alison M. ORCID logoORCID: https://orcid.org/0000-0002-5404-475X (2012) Dasatinib inhibits CXCR4 signaling in chronic lymphocytic leukaemia cells and impairs migration towards CXCL12. PLoS ONE, 7(11), e48929. (doi: 10.1371/journal.pone.0048929) (PMID:23133664) (PMCID:PMC3487834)

McCaig, Alison M., Cosimo, Emilio, Leach, Michael T. and Michie, Alison M. ORCID logoORCID: https://orcid.org/0000-0002-5404-475X (2011) Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro-survival microenvironmental signals. British Journal of Haematology, 153(2), pp. 199-211. (doi: 10.1111/j.1365-2141.2010.08507.x)

Michie, Alison M. ORCID logoORCID: https://orcid.org/0000-0002-5404-475X, McCaig, Alison M., Nakagawa, Rinako and Vukovic, Milica (2010) Death-associated protein kinase (DAPK) and signal transduction: regulation in cancer. FEBS Journal, 277(1), pp. 74-80. (doi: 10.1111/j.1742-4658.2009.07414.x)

This list was generated on Fri Jul 4 16:19:14 2025 BST.